InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
61,776.35
(
-0.48%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120535
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Monday, 09/03/2007 11:23:46 PM

Monday, September 03, 2007 11:23:46 PM

Post# of 19309
Notes on Artisan Pharma’s program in DIC/sepsis:

#msg-22260580 How big a threat is ART-123?
#msg-22257491 Phase-2b trial begins in US
#msg-21829339 clinicaltrials.gov listing of above trial
#msg-22326569 Paper on ART-123 study in Japan
#msg-22288440 Musings on the Japanese study (Dew)
#msg-22328879 Musings on the Japanese study (shears)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up